Sally Mandour/LinkedIn
Aug 13, 2026, 08:23
Sally Mandour: The Diagnostic Challenge of Hypocellular Bone Marrow Failure
Sally Mandour, Associate Professor, Head of Hematology Unit at Clinical Pathology Department of National Liver Institute, Monofeya University, shared a post on LinkedIn:
“Aplastic Anaemia is defined by the presence of pancytopenia with an empty bone marrow , by exclusion of marrow aplasia due to direct effect of chemotherapy or radiotherapy or any underlying pathological marrow condition.
Diagnosis difficulty is due to the number of marrow failure syndromes having a similar presentation.
Aplastic Anaemia vs. Hypoplastic MDS: Two Empty Marrows, Two Very Different Diseases
- Both present with pancytopenia and a ’empty,’ fat-replaced marrow.
- Both are driven by an oligoclonal CD8+ T-cell attack on haematopoietic stem cells. On a low-power view.
But one is an autoimmune bone marrow failure state. The other is a clonal neoplasm
5 differentiating tips:
- Dysplasia — subtle dysgranulopoiesis, megakaryocyte atypia, or ring sideroblasts favour MDS-h; a ‘clean’ hypoplastic marrow favours AA.
- Blasts — even a mildly increased blast percentage tips the scale toward MDS-h.
- Cytogenetics — clonal abnormalities (del(5q), del(7q), trisomy 8, del(20q)) support MDS-h; a normal karyotype supports AA (though AA is not always normal either).
- Molecular profile — BCOR/BCORL1 and PIGA mutations are typically ‘benign passengers’ in AA and predict a good response to immunosuppression. TP53, RUNX1, and multi-hit mutations point toward MDS-h/high-risk disease.
- PNH clone — a sizeable PNH clone (flow cytometry: CD55/CD59/FLAER) supports immune-mediated AA rather than MDS-h.”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition